The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
yeah and so this is exactly where diseases like alzheimer's disease or vascular dementia any form of dementia represents a deep painstaking challenge compared to atherosclerosis where you can have an event within a couple of years and still see an effect on plaque reduction lower event rates whether it's mri or amputations or strokes dementia on the other hand is much more subtle much more complicated and requires completely new set of tools
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.